04.12.2017 Views

Advanced Trauma Life Support ATLS Student Course Manual 2018

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

TETANUS IMMUNIZATION<br />

Overview<br />

Tetanus is a potentially fatal noncommunicable<br />

disease caused by the toxin (tetanospasmin).<br />

It is produced by the spore-forming bacteria<br />

Clostridium tetani, an anaerobic Gram-positive bacillus.<br />

The spores are hardy, resistant to heat and antiseptics,<br />

and found ubiquitously in the soil and feces of humans<br />

and animals. Successful treatment depends on proper<br />

care and treatment of wounds and traumatic injuries and<br />

prevention through appropriate tetanus immunization.<br />

Worldwide, tetanus still accounts for 1 million<br />

hospital admissions. Most of these cases are in Africa<br />

and Southeast Asia, but they are decreasing with<br />

immunization initiatives directed to these areas. In<br />

2012, tetanus caused 213,000 deaths worldwide. Most<br />

of these deaths occurred in developing countries, and<br />

one-half were in neonates. Mortality in these areas<br />

remains high (30% to 70%). In industrialized countries,<br />

mortality from tetanus is lower. The CDC reports case<br />

fatality of 13.2% in the United States.<br />

Tetanus is almost entirely preventable with adequate<br />

immunization. The disease has been central to the World<br />

Health Organization (WHO) Expanded Programme on<br />

Immunization since 1974. The incidence of tetanus<br />

decreases when immunization programs are in place.<br />

Unfortunately, under-immunized populations exist<br />

even in high-income countries. During the surveillance<br />

period of 2001–2008 in the United States, 233 cases<br />

associated with 26 deaths were reported. Individuals<br />

over the age of 50 represented one-half of those cases,<br />

and individuals over 65 represented 30% of the cases.<br />

Death was five times more likely in people older than<br />

65. Older women are particularly at risk, because most<br />

of those over age 55 do not have protective levels of<br />

tetanus antibody. Diabetics and injection drug users<br />

are other high-risk groups. Tetanus can occur in nonacute<br />

wounds, and 1 of 6 cases surveyed was associated<br />

with non-acute wounds.<br />

Inadequate tetanus toxoid vaccination and<br />

inadequate wound prophylaxis are the most important<br />

factors associated with the development of tetanus.<br />

Tetanus surveillance data have demonstrated two<br />

interesting findings: Fewer than 4% of those with acute<br />

wounds who sought treatment received appropriate<br />

prophylaxis. Only 36.5% sought immediate medical<br />

care for their wounds. All medical professionals must<br />

be cognizant of these factors when providing care to<br />

injured patients.<br />

Tetanus immunization depends on the patient’s<br />

previous immunization status and the tetanus-prone<br />

nature of the wound. The following guidelines are<br />

adapted from the literature, and information is available<br />

from the Centers for Disease Control and Prevention<br />

(CDC). Because this information is continuously<br />

reviewed and updated as new data become available,<br />

the American College of Surgeons Committee on<br />

<strong>Trauma</strong> recommends contacting the CDC for the most<br />

current information and detailed guidelines related<br />

to tetanus prophylaxis and immunization for injured<br />

patients. National guidelines may vary.<br />

Pathophysiology<br />

Clostridium tetani spores are found in the soil and in<br />

the feces of animals and humans. The spores access<br />

the body through breaks in the skin and grow under<br />

low oxygen conditions. Wounds that tend to propagate<br />

spore development are typically puncture wounds<br />

and wounds with significant tissue destruction.<br />

Tetanospasmin causes tetanus by blocking inhibitory<br />

pathways (gamma-aminobutyric acid), producing<br />

sustained excitatory nervous impulses that give rise<br />

to the typical clinical symptoms. Once the spores<br />

gain access to the body through an open wound, they<br />

undergo an incubation period of from 1 to 2 days and<br />

as long as 7 to 21 days. The diagnosis is usually clinical,<br />

and the treatment is supportive. Prevention is the<br />

mainstay of treatment.<br />

Types of wounds likely to encourage the growth of<br />

tetanus organisms include<br />

••<br />

Open fractures<br />

••<br />

Deep penetrating wounds (> 1 cm)<br />

••<br />

Stellate or avulsion configuration<br />

••<br />

Wounds containing devascularized tissue<br />

••<br />

Wounds resulting from a missile (gunshot<br />

wound)<br />

••<br />

Wounds from burns or frostbite<br />

n BACK TO TABLE OF CONTENTS<br />

407

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!